Benedikt Westermann

Benedikt Westermann

Auto-generated profile, based on publicly available information

Benedikt Westermann

Cell Biology, University of Bayreuth, Bayreuth, Germany

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 1998 in Cell
Verified
Journal Article
Closed access
TWThomas Weber
Thomas Weber
BZBoris V Zemelman
Boris V Zemelman
JMJames A. McNew
James A. McNew
BWBenedikt Westermann
Benedikt Westermann
MGMichael Gmachl
Michael Gmachl
JRJames E Rothman
James E Rothman

23 November 2010 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
BWBenedikt Westermann
Benedikt Westermann

6 July 2012 in Science
Verified
Journal Article
Closed access
PDF file
SHSébastien Herzig
Sébastien Herzig
EREtienne Raemy
Etienne Raemy
SMSylvie Montessuit
Sylvie Montessuit
JVJean-Luc Veuthey
Jean-Luc Veuthey
NZNicola Zamboni
Nicola Zamboni
JMJean-claude Martinou
Jean-claude Martinou
Letting Pyruvate In: Transport of pyruvate is an important event in metabolism whereby the pyruvate formed in glycolysis is transported into mitochondria to feed into the tricarboxylic acid cycle (see the Perspective by Murphy and Divakaruni ). Two groups have now identified proteins that are components of the mitochondrial pyruvate transporter. Bricker et al. (p. 96 , published online 24 May) found that the proteins mitochondrial pyruvate carrier 1 and 2 (MPC1 and MPC2) are required for full pyruvate transport in yeast and Drosophila cells and that humans with mutations in MPC1 have metabolic defects consistent with loss of the transporter. Herzig et al. (p. 93 , published online 24 May) identified the same proteins as components of the carrier in yeast. Furthermore, expression of the mouse proteins in bacteria conferred increased transport of pyruvate into bacterial cells.

1 October 2012 in Biochimica et Biophysica Acta (BBA) - Bioenergetics
Verified
Journal Article
Closed access
BWBenedikt Westermann
Benedikt Westermann

28 December 2009 in Journal of Cell Biology
Verified
Journal Article
Open access
SESarah Ehses
Sarah Ehses
IRInes Raschke
Ines Raschke
GMGiuseppe Mancuso
Giuseppe Mancuso
ABAndrea Bernacchia
Andrea Bernacchia
SGStefan Geimer
Stefan Geimer
TLThomas Langer
Thomas Langer
Mitochondrial fusion depends on the dynamin-like guanosine triphosphatase OPA1, whose activity is controlled by proteolytic cleavage. Dysfunction of mitochondria induces OPA1 processing and results in mitochondrial fragmentation, allowing the selective removal of damaged mitochondria. In this study, we demonstrate that two classes of metallopeptidases regulate OPA1 cleavage in the mitochondrial inner membrane: isoenzymes of the adenosine triphosphate (ATP)–dependent matrix AAA (ATPase associated with diverse cellular activities [m-AAA]) protease, variable assemblies of the conserved subunits paraplegin, AFG3L1 and -2, and the ATP-independent peptidase OMA1. Functionally redundant isoenzymes of the m-AAA protease ensure the balanced accumulation of long and short isoforms of OPA1 required for mitochondrial fusion. The loss of AFG3L2 in mouse tissues, down-regulation of AFG3L1 and -2 in mouse embryonic fibroblasts, or the expression of a dominant-negative AFG3L2 variant in human cells decreases the stability of long OPA1 isoforms and induces OPA1 processing by OMA1. Moreover, cleavage by OMA1 causes the accumulation of short OPA1 variants if mitochondrial DNA is depleted or mitochondrial activities are impaired. Our findings link distinct peptidases to constitutive and induced OPA1 processing and shed new light on the pathogenesis of neurodegenerative disorders associated with mutations in m-AAA protease subunits.

15 February 2008 in Genes & Development
Verified
Journal Article
Closed access
PDF file
CMCarsten Merkwirth
Carsten Merkwirth
SDSascha Dargazanli
Sascha Dargazanli
TTTakashi Tatsuta
Takashi Tatsuta
SGStefan Geimer
Stefan Geimer
BLBeatrix Löwer
Beatrix Löwer
TLThomas Langer
Thomas Langer
Prohibitins comprise an evolutionarily conserved and ubiquitously expressed family of membrane proteins with poorly described functions. Large assemblies of PHB1 and PHB2 subunits are localized in the inner membrane of mitochondria, but various roles in other cellular compartments have also been proposed for both proteins. Here, we used conditional gene targeting of murine Phb2 to define cellular activities of prohibitins. Our experiments restrict the function of prohibitins to mitochondria and identify the processing of the dynamin-like GTPase OPA1, an essential component of the mitochondrial fusion machinery, as the central cellular process controlled by prohibitins. Deletion of Phb2 leads to the selective loss of long isoforms of OPA1. This results in an aberrant cristae morphogenesis and an impaired cellular proliferation and resistance toward apoptosis. Expression of a long OPA1 isoform in PHB2-deficient cells suppresses these defects, identifying impaired OPA1 processing as the primary cellular defect in the absence of prohibitins. Our results therefore assign an essential function for the formation of mitochondrial cristae to prohibitins and suggest a coupling of cell proliferation to mitochondrial morphogenesis.